Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 672 of 767

Advanced search

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Galectin reaches FDA agreement on Phase 3 trial for belapectin

Investing.comOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Jaguar Health seeks full FDA approval for dog diarrhea drug

Stock TitanOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

FDA Approval of Semaglutide for Weight Loss Spurs Surge in U.S. Poison Control Calls, UT San Antonio Study Finds

Bioengineer.orgOriginal source

🌍Jun 23discoverynews.google.comTier 2 · Trade media

Pfizer delivers ‘disappointing’ late-stage lung cancer data for ADC from $43B Seagen buy

BioSpaceOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth

The ConversationOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Galectin Therapeutics Reaches FDA Agreement on Phase 3 Endpoint and Regulatory Path for Belapectin Full Approval

Quiver QuantitativeOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

The Manila TimesOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification

The Manila TimesOriginal source

🇨🇦Jun 23Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Optima XR240amx X-Ray System

Mobile X-ray column assembly issue on certain Optima XR200/220/240amx systems.

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jun 23Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Hoffmann® II Carbon Connecting Rod

Subsequent to product complaints, Stryker has confirmed that cracking of the Hoffmann® II Carbon Con...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jun 23Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

A.T.S® 4000 TS Tourniquet Systems Single and Dual Hose with CPC Connectors

Zimmer Biomet is conducting a medical device recall for A.T.S® 4000 TS Tourniquet Systems Single and...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

IMUNON ovarian cancer trial stays on track after safety review

Stock TitanOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines opens Phase 3 pancreatic cancer trial with zoldonrasib

Stock TitanOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

Yahoo! Finance CanadaOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

IMUNON Announces Data Monitoring Committee Recommends

GlobeNewswireOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Antidepressant Recall Expands Across the U.S.

Legal ReaderOriginal source

🌍Jun 23discoverynews.google.comTier 2 · Trade media

Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial

Fierce BiotechOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

GLP-1s took drug compounding to a new level. Empower Pharmacy cashed in.

Houston ChronicleOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Nuvectis (NASDAQ: NVCT) inks Haisco deal for NXP100 and BRAF drug NXP200

Stock TitanOriginal source

🇪🇺Jun 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Training Europe’s Future Leaders in AI-driven Neuro-Oncology Diagnostics and Discovery

CORDISOriginal source

🇪🇺Jun 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: First-in-Class Selective Nurr1:RXRα Modulators with a Unique Biophysical Mechanism driving multi-pathway Disease Modification in Parkinson’s Disease.

CORDISOriginal source

🇪🇺Jun 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: The First Multimodal GenAI Platform Delivering Precision Breast Cancer Diagnosis

CORDISOriginal source

🇪🇺Jun 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Mapping antigenic niches of tumor-infiltrating B cells in triple-negative breast cancer

CORDISOriginal source

🇪🇺Jun 23Regulatoryvaccineseurope.euTier 1 · Regulatory source

Vaccines Europe Welcomes New Leadership Team

Vaccines EuropeOriginal source

🌍Jun 23Industryamarin.co.thTier 3 · Secondary coverage

ฉลองครบรอบ 12 ปี อมรินทร์ทีวี และ 50 ปี อมรินทร์กรุ๊ป จัดตั้ง “กองทุนสื่อสานธรรม”

Amarin CorporationOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Atom Therapeutics Announces First Patient Dosed in China Phase 3 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Gout

Business WireOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

PleoPharma Begins Phase 3 Trial for Cannabis Withdrawal Drug

MyChesCoOriginal source

🌍Jun 23discoverynews.google.comTier 2 · Trade media

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

statnews.comOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

AnHorn's AI-Designed Drug Gets Green Light to Prevent Chemo Nerve Damage

BriefGlanceOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Amid a series of drug supply shortages and out-of-stock problems, Boryeong is taking the lead in sta..

매일경제Original source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV) maternal vaccination coverage in England: February 2026

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...

UK Health Security AgencyOriginal source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV) older adults vaccination coverage in England: May 2026

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...

UK Health Security AgencyOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Atsena’s ATSN-201 Gene Therapy Enrolls Rapidly in Phase 3 Trial for X-Linked Retinoschisis

The Clinical Trial VanguardOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Oppenheimer raises Definium Therapeutics stock price target on trial data By Investing.com

Investing.com IndiaOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Sex Representation vs. Disease Burden in FDA Trials

Bioengineer.orgOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Why Building Long-Term Value And Making Clinical Progress Are Inextricable

Clinical LeaderOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Health Brief: FDA signals reset in drug reviews

The Washington PostOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics Stock a No-Brainer Buy Below $35?

The Motley FoolOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Evonik Sells Hanau Pharmaceutical Ingredients Production Assets To ProChem

Pulse 2.0Original source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation

LelezardOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Biotech Chief Says Industry in ‘Better Place’ After FDA Changes

Bloomberg Law NewsOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Innovent-Pfizer deal makes joint development, commercialization pillar in biotech global push

China DailyOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

The Motley FoolOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

ETPharma.comOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

Yahoo FinanceOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

[BIO USA 2026] China’s biotech rise puts Korea on notice: KoreaBIO VP

koreabiomed.comOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Biotech Deals And Data Lit A Fire Under Small Caps

FinimizeOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation

StreetInsiderOriginal source

🇺🇸Jun 23Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇺🇰Jun 23Regulatorynice.org.ukTier 1 · Regulatory source

First disease-modifying therapy for NHS use to delay the onset of type 1 diabetes recommended

NICEOriginal source

🇿🇦Jun 23Researchnews.uct.ac.zaTier 2 · Direct publisher

UCT remains Africa's leading university and among top 5% globally

University of Cape TownOriginal source

🇺🇸Jun 23Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Jun 23Regulatoryfederalregister.govTier 1 · Regulatory source

Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)

In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for...

Federal RegisterOriginal source

🇺🇸Jun 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certification of Identity, Form FDA 3975

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source

🇺🇸Jun 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Potential Tobacco Product Violations Reporting Form

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...

Federal RegisterOriginal source

🇺🇸Jun 23Regulatoryfederalregister.govTier 1 · Regulatory source

Privacy Act of 1974; System of Records

In accordance with the requirements of the Privacy Act of 1974, as amended, the Department of Health...

Federal RegisterOriginal source

🇺🇸Jun 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Kopa Haiku Ringworm Treatment Cream

Official structured record identifier: 52cef8ec-6578-5e80-e063-6294a90ab423.

openFDA Drug LabelsOriginal source

🇺🇸Jun 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ibuprofen Mini Dye Free Advil

Official structured record identifier: 42c7dbec-2e53-70ae-e063-6294a90a16e6.

openFDA Drug LabelsOriginal source

🇺🇸Jun 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cold Sore Fever Blister Treatment

Official structured record identifier: 42b46e02-4d1f-411e-be9e-227f62ba5a86.

openFDA Drug LabelsOriginal source

🇺🇸Jun 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: dye-free pain relief

Official structured record identifier: 4227d0b7-846a-dcb0-e063-6294a90af7d7.

openFDA Drug LabelsOriginal source